SGCB and hydrops fetalis: Vericiguat is a novel soluble guanylate cyclase (sGC) inducer that enhancesendothelial function in HF patients by restoring the nitric oxide (NO)-sGC-cyclicguanosine monophosphate (cGMP) pathway, conferring cardiac and renal benefits[9].